🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Heidi Auman

University of Tasmania

ORCID: 0000-0002-8749-7843

Also affiliated with Canary Foundation, Palo Alto Institute

MedicineEnvironmental ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.165Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

Nature Communications(2025)10.1038/s41467-025-58145-2
Top 70%
0.165DataRank
Top 70%2 citations

Svetlana Djirackor, Dalia K. Omran, Euihye Jung, Natalie Shih, Ritu Roy +15 more

Papers

Driven by 6 papers — median percentile 30. Top paper: “Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube”.

Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube

Nature Communications(2025)10.1038/s41467-025-58145-2
Top 70%
0.165DataRank
Top 70%2 citations

Svetlana Djirackor, Dalia K. Omran, Euihye Jung, Natalie Shih, Ritu Roy +15 more

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009
N/A
0DataRank · unranked
25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241
N/A
0DataRank · unranked
8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Zebrafish smarcc1a mutants reveal requirements for BAF chromatin remodeling complexes in distinguishing the atrioventricular canal from the cardiac chambers

Developmental Dynamics(2023)10.1002/dvdy.595
N/A
0DataRank · unranked
6 citations

Ivy H. Fernandes, César A. Berríos‐Otero, Sophie Colombo, Deborah Yelon, Heidi Auman

Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

Histopathology(2024)10.1111/his.15231
N/A
0DataRank · unranked
30 citations

Lara R. Harik, Eric A. Klein, Jianbo Li, Dillon Corrigan, Shiguang Liu +18 more

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific Reports(2024)10.1038/s41598-023-50215-z
N/A
0DataRank · unranked
11 citations

Sarah Hawley, Christian A. Kunder, En‐Chi Hsu, Michelle Shen, Lennart Westphalen +17 more